Status: Recruiting
A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.
A two-part study of PRO-203 administered subcutaneously in healthy adult volunteers and participants with Systemic Sclerosis (SSc).
Participants needed: 44
Trial details
Phase: Phase 1, Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Prolium Bioscience, IncUpdated: Jun 18, 2026Locations: 3
Eligibility criteria
Is male or female, age 18 to 65 years, inclusive, at Screening. [+15]
Any clinically significant underlying illness in the opinion of the investigator... [+18]